Jyothy Labs: Business Overview & Financial Analysis
Jyothy Labs is a fast-moving consumer goods (FMCG) enterprise headquartered in Mumbai, Maharashtra. Founded in 1983 by M. P. Ramachandran, the company manufactures, markets, and distributes fabric care, dishwashing, household insecticides, and personal care products under flagship brand names including 'Ujala', 'Exo', 'Pril', 'Maxo', 'Margo', 'Henko', 'Mr. White', and 'Jovia' across domestic retail and international export markets.
Business Segment Revenue Breakdown of Jyothy Labs (FY2026)
Jyothy Labs categorises its operational turnover across core fabric care, dishwashing, personal care, and household insecticides business divisions.
- Fabric Care Division Share – 45.0% of Total Revenue
- Dishwashing Division Share – 31.0% of Total Revenue
- Personal Care Division Share – 10.0% of Total Revenue
- Household Insecticides Division Share – 10.0% of Total Revenue
- Others & Allied Products Share – 4.0% of Total Revenue
- Full Year Revenue from Operations (FY2026) – Rs 2,944.00 crore (+3.5% YoY)
Fabric care serves as the primary revenue engine, processing liquid whiteners and detergent powders. Dishwashing products and personal care soaps provide multi-category consumer reach across urban and rural markets.
Reclassified Category Revenue Mix of Jyothy Labs (Q1 FY2027)
Jyothy Labs structures its quarterly category reporting under three primary segments to better reflect consumer purchasing trends.
- Fabric Care Category Share – 52.0% of Category Revenue (Rs 399.00 crore)
- Home Care Category (Dishwashing & Insecticides) Share – 36.0% of Category Revenue (Rs 280.00 crore)
- Personal Care Category Share – 12.0% of Category Revenue (Rs 94.00 crore)
- Total Consolidated Operating Revenue (Q1 FY2027) – Rs 773.00 crore (+3.0% YoY)
Fabric care turnover expanded 14.1% year-on-year to Rs 399.00 crore during the first quarter. Home care and personal care categories sustained core market volumes despite commodity price headwinds.
Brand Portfolio & Market Positions of Jyothy Labs (FY2026)
Jyothy Labs manages a consumer brand library holding strong market positions across fabric whiteners, dishwashing bars, and mosquito repellents.
- Ujala Supreme Market Share – #1 position in Fabric Whitener category (~80%+ market share)
- Exo & Pril Market Share – #2 position in Dishwash segment by value
- Maxo Coils Market Share – #2 position in Mosquito Repellent Coils by volume (23.1% market share)
- Maxo Liquid Vaporizer Share – 8.9% market share in liquid vaporizer category
- Core Brands Portfolio – Ujala, Henko, Mr. White, Exo, Pril, Maxo, Margo, and Jovia
Flagship brand Ujala Supreme has maintained market leadership in liquid fabric whiteners for four decades. Exo and Pril represent key volume drivers in the domestic dishwash category.
Manufacturing Infrastructure & Distribution Reach of Jyothy Labs (FY2026)
Jyothy Labs manages a wide pan-India manufacturing and retail distribution architecture supplying retail outlets.
- Total Operational Manufacturing Plants Base – 23 production facilities across India
- Total Pan-India Retail Touchpoints Reach – ~4.0 million retail outlets
- Direct Retail Reach Outlets – 1.4 million retail outlets
- Authorised Channel Partners Base – 10,000+ distributors and channel partners
- Total Corporate Workforce Scale – 5,140 employees and 3,207 production workers
Operating 23 manufacturing facilities ensures localized product supply across regional markets. Direct distribution coverage of 1.4 million outlets provides retail shelf placement.
Latest Quarterly Financial Performance of Jyothy Labs (Q1 FY2027)
Jyothy Labs recorded steady top-line revenue expansion alongside margin adjustments during the first quarter of FY2027.
- Consolidated Revenue from Operations – Rs 773.00 crore (+3.0% YoY vs Rs 751.00 crore in Q1 FY2026)
- Consolidated Operating EBITDA – Rs 64.70 crore (-47.9% YoY vs Rs 124.20 crore in Q1 FY2026)
- Consolidated Operating EBITDA Margin – 8.40% (-810 bps YoY vs 16.50%)
- Gross Profit Margin Realisation – 38.50% (-950 bps YoY vs 48.00%)
- Consolidated Net Profit After Tax (PAT) – Rs 47.64 crore (-50.8% YoY vs Rs 96.80 crore in Q1 FY2026)
- Advertiing & Sales Promotion Outlay Share – 6.50% of Operating Revenue (Rs 50.60 crore)
First-quarter operating revenue rose 3.0% year-on-year to Rs 773.00 crore, supported by fabric care volume growth. Operating EBITDA stood at Rs 64.70 crore as crude-linked raw material inflation compressed gross margins.
Consolidated Annual Financial Performance of Jyothy Labs (FY2026)
Jyothy Labs achieved full-year turnover expansion and strong capital return ratios during full financial year FY2026.
- Full Year Consolidated Revenue from Operations – Rs 2,944.00 crore (+3.5% YoY)
- Full Year Underlying Volume Growth Rate – 6.0% YoY volume expansion
- Full Year Consolidated Net Profit After Tax (PAT) – Rs 333.00 crore
- Return on Equity (ROE) Realisation – 29.50%
- Return on Capital Employed (ROCE) Realisation – 39.26%
Full-year operating turnover crossed Rs 2,940 crore in FY2026, as consolidated Net Profit After Tax reached Rs 333.00 crore. Financial execution delivered return on capital employed of 39.26%.
Balance Sheet Structure & Financial Health of Jyothy Labs (Q1 FY2027)
Jyothy Labs maintains a capital structure supported by cash surplus reserves and zero bank debt borrowings.
- Financial Debt Status – Zero Debt / Net Cash Surplus (0.00x)
- Total Cash, Bank Balances & Treasury Reserves – Rs 997.00 crore
- Working Capital Conversion Cycle – 15 days
- Total Shareholder Net Worth Base – ~Rs 2,100.00 crore
The company operates a debt-free balance sheet backed by Rs 997.00 crore in liquid cash and treasury reserves. Maintaining a working capital cycle of 15 days ensures high operating cash flow conversion.
Product Innovation & Portfolio Expansion Roadmap of Jyothy Labs (FY2026–FY2027)
Jyothy Labs executes product innovation outlays to expand brand presence across personal care and household insecticides.
- Fabric Care New Launch – 'Ujala Young & Fresh' launched for domestic and overseas markets
- Insecticides Category Expansion – 'Maxo Knockout Spray' for mosquitoes, flies, and cockroaches
- Personal Care & Repellent Additions – 'Jovia' personal care range and 'Maxo Anti-Mosquito Racquet'
- Personal Care Revenue Share Target – Scaling revenue contribution from 12.0% to 15.0%
- Long-Term Corporate Turnover Target – Reaching Rs 5,000.00 crore annual revenue trajectory
Commercializing 'Ujala Young & Fresh' and 'Jovia' broadens product appeal among younger consumer segments. Portfolio rebalancing targets scaling personal care sales to 15% of total revenue.
Strategic Outlook & Management Commentary of Jyothy Labs (Q1 FY2027 Concall)
Management guidance outlines strategic priorities centered on retail expansion, price pass-through, and reaching Rs 5,000 crore turnover.
- Management targets navigating near-term margin pressures caused by crude-linked raw material price volatility.
- Retail distribution reach will be expanded by adding 50,000 to 100,000 outlets annually across general trade.
- Calibrated price increases of 4% executed in March 2026 will be followed by further price actions as required.
- Personal care segment revenue share is targeted to reach 15% through portfolio rebalancing.
- Long-term corporate revenue trajectory remains targeted toward the Rs 5,000.00 crore milestone.
- Capital allocation strategy will prioritize maintaining a debt-free, cash-surplus balance sheet while supporting brand spending.
Management anticipates volume growth across core categories despite short-term commodity price volatility. Operational focus centers on adding retail outlets, executing price hikes, and preserving balance sheet strength.
Want to filter out stocks based on your own investment criteria? You can use the Stock Screener on Finology Ticker to evaluate stocks based on customised valuation and profitability parameters.
Sources & References
- Jyothy Labs Q1 FY2027 Earnings Release & Financial Results Disclosures (August 5/12, 2026)
- Jyothy Labs Q1 FY2027 Earnings Call Summary & Category Analysis
- Jyothy Labs Stock Exchange Outcomes & BSE/NSE Filings
- Ticker Finology Jyothy Labs Page
Disclaimer
The information presented above on Jyothy Labs has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Jyothy Labs page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.